Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Fiscal Q2 2026Jun 30, 2026
Fiscal Q1 2026Mar 31, 2026
Quarter ended on Jun 30, 2025Jun 30, 2025
Quarter ended on Mar 31, 2025Mar 31, 2025
Money the company earns from selling products or services, before subtracting costs.
———
The direct costs of making or delivering what the company sells, such as materials, factory labor, or service delivery.
———
Money left from sales after paying the direct costs of what the company sells.Formula: Revenue − cost of revenue
The costs of running the business beyond making or delivering its products, such as research, marketing, and office expenses.
+494.6% YoY+63.4% YoY
Profit from the company’s main business, before taxes and income or costs outside those operations.Formula: Gross profit − operating expenses
-494.6% YoY-63.4% YoY
Money earned or spent outside the main business, such as investment income and interest on debt.Formula: Non-operating income − non-operating expenses
Profit before income taxes are taken out.Formula: Operating income + net non-operating income + pre-tax adjustments
-475.1% YoY-71.1% YoY
The income tax cost counted against the period’s profit, including amounts payable now or later.
The profit left after all expenses and taxes. A negative number means the company lost money.Formula: Total income − total expenses
-475.1% YoY-71.1% YoY
Profit for each ordinary share during the reporting period.Formula: Earnings available to common shareholders ÷ weighted-average basic shares
-65.7% YoY-33.3% YoY
Earnings per share adjusted so results before and after a stock split can be compared.Formula: Reported EPS ÷ cumulative subsequent split factor
-65.7% YoY-33.3% YoY
Profit per share after counting potential extra shares from stock awards or convertible securities that would reduce it.Formula: Diluted earnings available to common shareholders ÷ weighted-average diluted shares
-65.7% YoY-33.3% YoY
Earnings per share adjusted so results before and after a stock split can be compared.Formula: Reported EPS ÷ cumulative subsequent split factor
-65.7% YoY-33.3% YoY